<SEC-DOCUMENT>0001493152-21-014795.txt : 20210621
<SEC-HEADER>0001493152-21-014795.hdr.sgml : 20210621
<ACCEPTANCE-DATETIME>20210621081524
ACCESSION NUMBER:		0001493152-21-014795
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20210621
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
FILED AS OF DATE:		20210621
DATE AS OF CHANGE:		20210621

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celsion CORP
		CENTRAL INDEX KEY:			0000749647
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				521256615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15911
		FILM NUMBER:		211027507

	BUSINESS ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648
		BUSINESS PHONE:		(609) 896-9100

	MAIL ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELSION CORP
		DATE OF NAME CHANGE:	19980515

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEUNG LABORATORIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>WASHINGTON,
DC 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
of report (Date of earliest event reported): June 21, 2021 (June 18, 2021)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>CELSION
CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Exact
Name of Registrant as Specified in Charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>001-15911</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>52-1256615</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State
    or other jurisdiction</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
    incorporation)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Commission</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
    Number)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(IRS
    Employer</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Identification
    No.)</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>997
Lenox Drive, Suite 100</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lawrenceville,
NJ 08648</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s
telephone number, including area code: (609) 896-9100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    symbol(s)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">which
    registered</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock, par value<BR>
    $0.01 per share</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLSN</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
    Capital Market</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933
(&sect; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect; 240.12b-2 of this chapter).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
1.01 Entry into a Material Definitive Agreement.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
see the disclosure set forth under &ldquo;Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet
Arrangement of a Registrant,&rdquo; which is incorporated by reference into this Item 1.01.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 18, 2021, Celsion Corporation, a Delaware corporation (&ldquo;Celsion&rdquo;), entered into a $10 million loan facility (the &ldquo;SVB
Loan Facility&rdquo;) with Silicon Valley Bank (&ldquo;SVB&rdquo;). Celsion immediately used $6 million from this facility to retire
all outstanding indebtedness with Horizon Technology Finance Corporation. The remaining $4 million will be available to be drawn down
up to 12 months after closing and will be used for working capital and to fund the advancement of the Company&rsquo;s product pipeline,
including GEN-1 for the treatment of newly diagnosed advanced ovarian cancer, as well as other strategic initiatives intended to broaden
its product pipeline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SVB Loan Facility is in the form of money market secured indebtedness bearing interest at a calculated WSJ Prime-based variable rate
(currently 3.25%). A final payment equal to 3% of the total $10 million commitment amount is due upon maturity or prepayment of the loan
facility. There was no facility commitment fee and no stock or warrants were issued to SVB. Payments under the loan agreement are interest
only for the first 24 months after loan closing, followed by a 24-month amortization period of principal and interest through the scheduled
maturity date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the SVB Loan Facility does not purport to be complete and is qualified in its entirety by reference to the Horizon
Credit Agreement, a copy of which the Company intends to file as an exhibit to its Quarterly Report on Form 10-Q for the quarter ending
June 30, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Safe
Harbor Statement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Current Report on Form 8-K contains forward-looking statements. Actual results and the timing of events could differ materially from
those anticipated in such forward-looking statements as a result of risks and uncertainties including, without limitation, Horizon may
not issue additional loan tranches and has no obligation to issue them; Celsion may be unable to find suitable assets or companies to
acquire on attractive terms; any failure to satisfy the closing conditions of subsequent borrowings of the credit facility; any increase
in Celsion&rsquo;s cash needs; unforeseen changes in the course of Celsion&rsquo;s research and development activities and clinical trials;
possible actions by customers, suppliers, competitors or regulatory authorities; and other risks detailed from time to time in the Company&rsquo;s
periodic reports filed with the Securities and Exchange Commission. Celsion undertakes no obligation to update any forward-looking statement,
whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No.</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex99-1.htm">Press Release titled &ldquo;Celsion Corporation Enters into $10 Million Strategic Loan Facility with Silicon Valley Bank Update&rdquo; issued by Celsion Corporation on June 21, 2021.</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CELSION
    CORPORATION</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    21, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jeffrey W. Church</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    W. Church</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Vice President and Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 41.25pt; width: 102pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Celsion
Corporation Enters into $10 Million Strategic Loan Facility with Silicon Valley Bank</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Improvement
to the Balance Sheet Leverages Strong Equity Structure</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Retires
Debt and Gains Five Months of Operating Runway at Very Low Cost of Capital</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAWRENCEVILLE,
N.J. (June 21, 2021) &ndash; Celsion Corporation (NASDAQ: CLSN)</B>, a clinical-stage company focused on DNA-based immunotherapy and
next-generation vaccines, announces it has entered into a $10 million loan facility with Silicon Valley Bank (SVB). Celsion immediately
used $6 million from this facility to retire all outstanding indebtedness with Horizon Technology Finance Corporation. The remaining
$4 million will be available to be drawn down up to 12 months after closing and will be used for working capital and to fund the advancement
of the Company&rsquo;s product pipeline, including GEN-1 for the treatment of newly diagnosed advanced ovarian cancer, as well as other
strategic initiatives intended to broaden its product pipeline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;This
loan facility provides us with financial and operating flexibility at very favorable terms, strengthens our balance sheet with the elimination
of the Horizon debt and allows us to meet several key, value-driving milestones with our product-development initiatives,&rdquo; said
Michael H. Tardugno, Celsion&rsquo;s chairman, president and chief executive officer. &ldquo;Including the $4 million that will become
available to us in a year, we will have sufficient cash to fund current and planned operations into early 2025. We appreciate the support
of SVB and their confidence in Celsion and the management team.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tom
Gordon, Managing Director of Life Science and Healthcare at Silicon Valley Bank, said, &ldquo;We are pleased Celsion has selected SVB
as its financial partner for this $10 million loan facility. We have confidence in the Company&rsquo;s business strategy and look forward
to Celsion reaching critical milestones including with GEN-1 for ovarian cancer and other strategic initiatives to broaden its product
pipeline.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
funding is in the form of money market secured indebtedness bearing interest at a calculated WSJ Prime-based variable rate (currently
3.25%). Payments under the loan agreement are interest only for the first 24 months after loan closing, followed by a 24-month amortization
period of principal and interest through the scheduled maturity date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Silicon Valley Bank</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
nearly 35 years, Silicon Valley Bank (SVB) has helped innovative companies and their investors move bold ideas forward, fast. SVB provides
targeted financial services and expertise through its offices in innovation centers around the world. With commercial, international
and private banking services, SVB helps address the unique needs of innovators. Learn more at <U>svb.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Celsion Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celsion
is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative cancer treatments, including
immunotherapies and DNA-based therapies; and a platform for the development of nucleic acid vaccines currently focused on SARS-CoV2.
The company&rsquo;s product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer. ThermoDox&reg;,
a proprietary heat-activated liposomal encapsulation of doxorubicin, is under investigator-sponsored development for several cancer indications.
Celsion also has two platform technologies for the development of novel nucleic acid-based immunotherapies and other anti-cancer DNA
or RNA therapies. Both are novel synthetic, non-viral vectors with demonstrated capability in nucleic acid cellular transfection. For
more information on Celsion, visit <U>www.celsion.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Forward-looking
statements in this news release are made pursuant to the &ldquo;safe harbor&rdquo; provisions of the Private Securities Litigation Reform
Act of 1995. Readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation,
statements relating to the offering and the use of proceeds therefrom, unforeseen changes in the course of research and development activities
and in clinical trials; the uncertainties of and difficulties in analyzing interim clinical data, particularly in small subgroups that
are not statistically significant; FDA and regulatory uncertainties and risks; the significant expense, time and risk of failure of conducting
clinical trials; the need for Celsion to evaluate its future development plans; possible acquisitions or licenses of other technologies,
assets or businesses; possible actions by customers, suppliers, competitors or regulatory authorities; and other risks detailed from
time to time in the Celsion&rsquo;s periodic filings with the Securities and Exchange Commission. Celsion assumes no obligation to update
or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONTACTS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Celsion
Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
W. Church</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
Vice President and CFO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">609-482-2455<BR>
<U>jchurch@celsion.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LHA
Investor Relations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kim
Sutton Golodetz</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">212-838-3777</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>kgolodetz@lhai.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">#
# #</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MV]AJMAIKS6UR@4F-QC# $8S]16E.#J34%NP/3/, 7)R!WS3E8-R*_*3]G/\
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M/^";OQ&F\:_ %-)N[HW%[X<OI+ !VRPMR!)$?H-SH/:.O3OVPO\ DV?XB_\
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M^KZ<6TN^D8DL\D0 5R<]60HQ]RU<M_P4D7/[+^I'_J(V?_HRO-_^"4NI3S>
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MV\D<9VZY+CH13PM=^Z]O\A23W1]N? 7XX:'\?? -GXET614+ 1WED7S):3@
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M"?\ +0,2,[@=W'MC;"Y/B<0G*2Y4NXG*Q^U:Q*K;@.?6O'_VPO\ DV?XB_\
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M%?C!^VM\4+?XK?M$>(]0L+I;O2=/\O2[.5&RK)$"&*GNID,C#'8BO>?VIO\
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MNM>%?MP_\FK_ !!_Z]8?_2B*O%PG^\4_\2_,;V/S _8]_P"3F_AW_P!A1/\
MT%J*/V/?^3G/AW_V%$_]!:BOH^(/]XCZ?J52V9^VE,>-6R=N3UI],:7:V,5\
MD(^7_CU^P+X"^,5Q<ZOI@?P?XCFRS7>GQ!H)G/.Z6#(!.<Y*E3SSFOBKQ]_P
M3H^,'@^0MIFFV?BRUS_K=*N55P,\;HY2IS_NYK]<_M YX'YU(K;ES7M8;-\5
MA4HIW7F2XIGX?S?LG_&*&0HWPX\1$C^Y9,P_ C/Z&MGP_P#L4?&OQ%<1QP>
M=1M QYDOWCME4>I\Q@?R%?M117H?ZPXCI%+[Q<B/SH^$W_!+6[^UQ7?Q%\1Q
M"W7#'3-#W%F]FF=1@>RJ<^HZU]Z^!_ 'A[X<^&[70?#6D6VCZ5;CY+:V7 R>
MK,>K,<<LV2>]=%17B8K'5\8_WLKHI)+815"]*YOQ]\/O#WQ)\,W>@>)=*AU?
M2;K'FV\V>HZ,I'*L.S*01VKI:*X8R<6I1=F,_-CXM?\ !+G6K6^FN_AWKL%_
M8D;UTW6F,4Z'^ZLJJ5?_ ($%_K7@U[^PS\<K"X,+^ ;J4YP'@N[:13[@B7IS
MWK]H**^BI9]BJ<>65GZD<B/R(\&_\$XOC-XFG']HZ7I_A>WX/FZE?1N3SSA8
M2YS]<5]H_LW_ +!OA'X(WEOKNK2CQ9XKBPT=U<0A;>U;/6*/)PP_OL2>.-O(
MKZFHKFQ.;XK%1<&[+R&HI;#%C4 <<]:X/X]>!;_XG?"'Q7X5TR6""_U6Q>VA
MENBPC5CC!8@$X^@-=_3))1&0#]:\B$G"2E'=%'YV?!'_ ()V_$+X:?%OPGXI
MU+6O#\]AI-_'=31VTTQE95ZA08@,_4BOT25-ZG<,_6I <@?G175BL95QDE*J
M]4)*Q\>_M+?\$^]"^,6J77B3PM>1^%O$]RQDN4:(M:7DG)+N!\R.<\LN<X^[
MDDU\<^*/^">_QM\.W4B6_AF'7;=3@76FW\+*WN%D97_-:_8BBN_#YSBL-%03
MNO,3BGJ?C1HG[!?QRUJX2/\ X0I[&-CAI[V^MXE7GJ?WF[ ]E-?37P+_ ."8
MUOH6K6VK?$O5;?61 ZNNBZ9O^SN1S^]E8!F'^RJCZGI7W[16E?.\76CR*T4^
MPE%(S)_#VGSZ8NG&TB6S50BQ(NU4   "@=, ?I7F_P 0_ NL7?PY\9>%;.ZC
MDL-8T6^L8);G.+:26!T4L0"=N6&<#@#I7K0H8;A@U\?6P<*E:.*CI4CL_P!'
MW1V4Z\HQ=-ZQ?3]?4_,WX2?\$[?'GA_X@>%O$I\1^&;VPTK5;6]F6UN)V=DB
ME1V !B'S8'<BOT1D\42:7)LU6U>VCSQ=1@O$>?S7\?SI;WPG']J-YITS:=>G
MJ\8RC^S+T/\ .B/5KFU41:Q:;$^[]HA&^,^[8Y7\>/>ECLSQ^+<?K3Y91V:5
MXOUZK^M36%.EO#5=MG\N_P#6AJV>H6>J1^9;SQSITW(V?ZU\^?M$_L3>"?C]
M-+JWS^&O%;+@ZM8Q!A-@8'GQ\"3  &00W YP,5[)=>"M(U;-Q9LUK(W(FLWP
M/R'%9\GAGQ-IZXT_7/M"#^&X'/YD-7)3S;,<!+VGL7*W6#3_  =OU*^KT*GP
MU+/S7ZJY^9GCC_@FW\7_  Q*QT>VTWQ9;9.&L+M89 !W*3%.3Z*37%0?L/?&
M^>4QGP'<0!3\TEQ>VL2 =R6:7&/H:_5V:#QVP*^<A']Y3'S^E9<W@CQ/JTG^
MF39&<GSIB1^0S7;4\0,RC'DHX&<I?WE9?FS>&64K\U2O%+R=SX!\!?\ !/F_
M:>"Y\<^*+*PM/O/I^ADW5RW/W3(0(T_WAO\ I7W9\!_A+HO@?1H;30='CT;0
M;=A)'"#NENY<8\Z5SR[>YX';%=CH?PLM+-UEOI3>.#D1XVIGW]:[>&-84"JH
M4 8  X%>?'%9YG515<VDH4UJJ<>KZ<SZV[!6EA,/%PPRN_YG^@]5 4 =.E>+
M_M;?!O6?CM\';KPGH=S:6E_-=03B6^9EC"QON(.U6.3]*]IHKZ2E4E1FJD=T
M>1Y'PW^R)^P_XV^ ?Q@A\5:]JFBWE@MC/;&.QEF:7<^W!PT8&.#WK[DHHK;%
M8JIBY^TJ[B2MH@KS+]H[X<:I\7/@SXG\(:1-;V]_JD*1PR71*Q*PE1\L0"<8
M4]!7IM%<].;IR4X[H9^=WP'_ .">?Q!^%WQ@\)^*]3UKP_<6&E7JW$T=K-,9
M64*1\H,0&>>Y%%?HC177B<96QDE.J]4)>Z5=4OH=,L)[RYE6&WMXVEED8X"J
MJDEC[  _E7P/X5M/'?\ P4"\5:_JE[XEU'P?\(K"Z:RM]-TYBDM[@;@&.-K-
M@JS%L@;@ .IK[-^->BWOB3X/^.-)TT%M0O\ 0[ZUM@#@F5[=U0 _[Q%>#_\
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M8DJ>V:\3F>[\+?M6?!S6M.^%,WP<.M7SZ?<V4=U"8K^(F-'_ '$0 CP).<J
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MBB@".92R@ 9.?I7R9\0OV0/%OAGX@7WCSX'>+D\%ZSJ4GF:EH]TN;"X;.2P
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MD%NA\W?L^_LNZSX$\::K\1OB%XA7Q=\1=2C\@W4:E8+6(@ K&,#)( &=HP.
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' 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
